[Lymphadenectomy in the operative treatment of renal pelvic and ureteral carcinoma].

We evaluated 18 patients with renal pelvic and ureteral carcinoma focusing on the operative treatment. All the patients underwent nephroureterectomy and partial cystectomy, except for two patients, with CIS of the ureter and renal insufficiency, and one with invasive bladder carcinoma, in whom partial ureterectomy and total cystectomy were performed, respectively. Lymphadenectomy were performed in all the patients and resected lymph nodes were from renal hilus, para-aorta or vena cava, according to the affected side, intra aorto-caval and all the pelvic nodes in the affected side. Lymph node metastases were found in 4 patients (22%), 2 in the primary and distant nodes and the other in the regional nodes only. Skipped lesion of the lymph node metastasis was not rare and lymph node dissection from the renal hilus to the pelvis on the affected side should be included in the operative treatment of renal and ureteral carcinoma.

[1]  S. Streem Percutaneous management of upper-tract transitional cell carcinoma. , 1995, The Urologic clinics of North America.

[2]  U. Studer,et al.  Percutaneous bacillus Calmette-Guerin perfusion of the upper urinary tract for carcinoma in situ. , 1989, The Journal of urology.

[3]  J. Montie,et al.  Conservative surgery for transitional cell carcinoma of the renal pelvis. , 1987, The Journal of urology.

[4]  W. Catalona Surgical staging of genitourinary tumors , 1987, Cancer.

[5]  E. Pontes,et al.  Percutaneous management of upper tract transitional cell carcinoma. , 1986, The Journal of urology.

[6]  H. Bloom,et al.  Percutaneous renal surgery and local radiotherapy in the management of renal pelvic transitional cell carcinoma. , 1986, British journal of urology.

[7]  W. Whitmore,et al.  Consideration for treatment of upper urinary tract tumors with topical therapy. , 1986, Urology.

[8]  H. Herr Durable response of a carcinoma in situ of the renal pelvis to topical bacillus Calmette-Guerin. , 1985, The Journal of urology.

[9]  W. Whitmore,et al.  Endoscopic diagnosis and treatment of upper‐tract urothelial tumors. A preliminary report , 1985, Cancer.

[10]  C. Servadio,et al.  Long-term intravesical thiotepa treatment in patients with superficial bladder tumors and vesicoureteral reflux. , 1985, The Journal of urology.

[11]  F. Marshall,et al.  In situ management of renal tumors: renal cell carcinoma and transitional cell carcinoma. , 1984, The Journal of urology.

[12]  E. Vaughan,et al.  Carcinoma of the ureter: natural history, management and 5-year survival. , 1983, The Journal of urology.

[13]  T. Kakizoe,et al.  Transitional cell carcinoma of the bladder in patients with renal pelvic and ureteral cancer. , 1980, The Journal of urology.

[14]  K. Cummings Nephroureterectomy: rationale in the management of transitional cell carcinoma of the upper urinary tract. , 1980, The Urologic clinics of North America.

[15]  P. Mechali [Tumors of the bladder]. , 1978, Soins; la revue de reference infirmiere.

[16]  S. Johansson,et al.  A clinicopathologic and prognostic study of epithelial tumors of the renal pelvis , 1976, Cancer.

[17]  W. Whitmore,et al.  Primary carcinoma of the ureter: A prognostic study , 1975, Cancer.

[18]  C. Williams,et al.  Carcinoma of the renal pelvis: a review of 43 cases. , 1973, British journal of urology.

[19]  S. A. Vest Conservative Surgery in Certain Benign Tumors of the Ureter1 , 1945 .